UPC upholds pharmaceutical patent for subgroup of patients: Key lessons for patent holders and challengers

On 9 October 2026, the Milan section of the Central Division of the Unified Patent Court (UPC) rejected Biogaran’s revocation action against Lundbeck’s European patent EP 4 223 296 (UPC_CFI_1587/2025)….
By: McDermott Will & Schulte